Dr. Barba is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9300 Campus Point Dr
La Jolla, CA 92037Phone+1 619-543-5540Fax+1 858-657-6538
Summary
- Dr. David Barba is an attending neurosurgeon at the UC San Diego Health Care system based in La Jolla at the Jacobs Medical Center. He is affiliated with multiple hospitals in the area, including UC San Diego Medical Center – Hillcrest, and VA San Diego Healthcare System. He received his medical degree from Keck School of Medicine of USC and has been in practice 38 years. He specializes in stereotactic & functional neurosurgery and is experienced in MRI guided asleep stereotactic DBS surgery for Parkinson's disease and other movement disorders. He is he also has a special interest in epilepsy surgery.
Education & Training
- University of California (San Diego) Medical CenterResidency, Neurological Surgery, 1980 - 1985
- University of Southern California/LACUSC Medical CenterInternship, Transitional Year, 1979 - 1980
- Keck School of Medicine of the University of Southern CaliforniaClass of 1979
Certifications & Licensure
- CA State Medical License 1980 - 2025
- American Board of Neurological Surgery Neurological Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
- Join now to see all
Publications & Presentations
PubMed
- 197 citationsNerve Growth Factor Gene Therapy: Activation of Neuronal Responses in Alzheimer DiseaseMark H. Tuszynski, Jennifer H. Yang, David Barba, Hoi-Sang U, Roy A.E. Bakay
JAMA Neurology. 2015-10-01 - 135 citationsAdeno-Associated Viral Vector (Serotype 2)-Nerve Growth Factor for Patients With Alzheimer Disease: A Randomized Clinical Trial.Michael S. Rafii, Mark H. Tuszynski, Ronald G. Thomas, David Barba, James B. Brewer
JAMA Neurology. 2018-07-01 - 152 citationsA phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease.Michael S. Rafii, Tiffany L. Baumann, Roy A.E. Bakay, Jeffrey M. Ostrove, Joao Siffert
Alzheimer's & Dementia. 2014-09-01
Journal Articles
- Postmortem Analysis in a Clinical Trial of AAV2-NGF Gene Therapy for Alzheimer's Disease Identifies a Need for Improved Vector DeliveryMichael J. Castle, Fernando C. Baltanás, Imre Kovacs, Alan H. Nagahara, David Barba, and Mark H. Tuszynski, Human Gene Therapy, 4/16/2020
Press Mentions
- First Real-Time Mri-Guided Brain Surgery for Parkinson's in Southern CaliforniaDecember 16th, 2014
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: